Project: Polypharmacology drug discovery platform to unlock novel chemical space for chemokine therapeutics

Acronym PROTEUS (Reference Number: 12132)
Duration 01/04/2018
Project Topic InterAx Biotech and Stichting VU (Vrije Universiteit Amsterdam) will combine complementary technologies to design bioactive molecules that simultaneously target multiple chemokine receptors. A combination of systems biology, virtual screening and novel protein-based biosensors will allow for the design of new chemical modulators with well-defined polypharmacological effects that can serve as new therapeutics. This unique process will accelerate drug discovery for unmet needs in oncology.
Network Eurostars 2
Call Eurostars Cut-Off 8

Project partner

Number Name Role Country
1 InterAx Biotech AG Coordinator Switzerland
2 Stichting VU (Vrije Universiteit Amsterdam) Partner Netherlands